Matrix Laboratories Limited (MAXL.BO) Completes Name Change to Mylan Laboratories Inc. (MYL)
10/19/2011 11:35:30 AM
More...
|
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Gets Tentative FDA Approval for AIDS Drug
9/20/2011 6:55:57 AM
More...
|
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Approval for Generic Version of Aricept(R) Tablets
6/7/2011 11:34:39 AM
More...
|
Mylan Inc. (MYL) to Rebrand Matrix Laboratories Limited (MAXL.BO)
5/27/2011 6:37:43 AM
More...
|
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
3/10/2011 6:51:27 AM
More...
|
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Approval for Generic Version of Neurontin(R) Capsules
2/28/2011 10:00:45 AM
More...
|
Tibotec Pharmaceuticals Ltd Signs Multiple Agreements With Generic Manufacturers, Including Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO), Aspen Pharmacare Holdings and Hetero Drugs to Provide Access to New HIV Treatment
1/27/2011 8:00:52 AM
More...
|
Another Gastroesophageal Reflux Disease Drug Goes Generic by Matrix Laboratories Limited (MAXL.BO)
1/26/2011 6:21:00 AM
More...
|
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets, 30 mg/60 mg
1/20/2011 7:17:10 AM
More...
|
Mylan Inc. (MYL) Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories Limited (MAXL.BO)' New Drug Application (NDA) for Efavirenz Tablets
12/22/2009 7:04:11 AM
More...
|
|